Trial Profile
Tolerability and Immunogenicity Study of FLUVAL P Monovalent Influenza Vaccine in Adults and Elderly Persons.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Sep 2017
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine
- Indications Influenza A virus H1N1 subtype; Influenza A virus infections; Influenza B virus infections
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Sponsors Fluart Innovative Vaccines
- 19 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Oct 2011 Actual end date (February 2010) added as reported by ClinicalTrials.gov.
- 16 Dec 2009 Results were published in the Lancet.